Jenika Errato
Family · Bluffton, SCNPI 1790314524
Payments from drug & device makers
Across 149 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$264
- AbbVie$241
- Novartis$224
- Otsuka America Pharmaceutical, Inc.$206
- GSK$202
- AstraZeneca$152
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,601100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $264 |
| AbbVie | 15 | $241 |
| Novartis | 11 | $224 |
| Otsuka America Pharmaceutical, Inc. | 10 | $206 |
| GSK | 11 | $202 |
| AstraZeneca | 9 | $152 |
| Lilly USA, LLC | 7 | $143 |
| Sanofi-aventis U.S. LLC | 6 | $141 |
| Abbott | 5 | $107 |
| Axsome Therapeutics, Inc. | 4 | $98 |
| Amarin Pharma, Inc. | 4 | $72 |
| Johnson & Johnson | 4 | $70 |
| Idorsia Pharmaceuticals US Inc | 4 | $67 |
| Shield Therapeutics Inc | 3 | $64 |
| Kowa Pharmaceuticals America, Inc. | 4 | $59 |
| Indivior Inc. | 3 | $50 |
| Bayer | 2 | $46 |
| Exact Sciences | 3 | $45 |
| Pfizer | 2 | $44 |
| Corium, LLC | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $35 |
| Lundbeck LLC | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Cvrx, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Merck | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Boehringer Ingelheim | 1 | $11 |
How this compares
$2,601 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 37 | $57,852 |
| MounjaroTirzepatide | 17 | $24,743 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $17,499 |
| JanuviaSitagliptin Phosphate | 14 | $13,893 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $9,407 |
| LinzessLinaclotide | 13 | $8,424 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,369 |
| Paroxetine ErParoxetine Hcl | 12 | $898 |
| Valsartan | 36 | $584 |
| Amlodipine Besylate | 61 | $572 |
| Levothyroxine Sodium | 34 | $524 |
| Omeprazole | 35 | $472 |
| Losartan Potassium | 37 | $399 |
| Pioglitazone Hcl | 15 | $369 |
| Pravastatin Sodium | 23 | $311 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $264 | $57,85237 claims |
| Lilly USA, LLCMounjaro | $143 | $24,74317 claims |
| GSKTrelegy Ellipta | $202 | $17,49917 claims |
| MerckJanuvia | $14 | $13,89314 claims |
| AbbVieLinzess | $241 | $8,42413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,248 family providers in South Carolina.
Other family in Bluffton
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.